Plan an epidermoid cyst removal budget from an actual Korean quote
An epidermoid cyst is a sac beneath the skin that contains keratin. It is often called a sebaceous cyst in everyday conversation, but appearance alone cannot distinguish it from another cyst, a lipoma, an abscess, or a skin tumor. A clinician must establish the diagnosis before cost planning can be meaningful. This calculator does not decide whether a lesion should be removed, when an operation should occur, which anesthetic should be used, or whether Korean National Health Insurance applies.
The patient bill can vary with lesion count, anatomic location, depth, inflammation, closure difficulty, outpatient or operating-room setting, and whether anesthesia, materials, pathology, medicine, dressings, and follow-up are bundled. Covered patient cost, full patient payment within the benefit system, and non-covered charges may also appear on the same statement. A single nationwide average would hide those differences, so this planner starts with the written provider estimate or the patient amounts on a detailed bill.
The detailed Korean calculator separates every component and compares a base removal plan with a separately quoted staged-care scenario. The English quick planner uses the complete itemized household cost as its primary amount, subtracts confirmed insurance or public support only, adds a contingency reserve, and divides the target across the selected funding period.
Use the bill structureKeep covered patient payment, full patient payment, and non-covered charges separate so a percentage is not applied twice.
Check omitted itemsConfirm consultation, imaging when used, anesthesia, pathology, medicines, dressings, follow-up, travel, and work loss.
Compare two quotesKeep an inflammation-stage treatment quote separate from the base removal plan without inventing a probability.
How the 2026 Korean coverage framework affects a quote
National Health Insurance Act Articles 41 and 44 provide the benefit and patient cost-sharing framework. The current act was checked in MST 276651, effective January 2, 2026. Enforcement Decree Article 19 sends patient cost sharing to Annex 2. The current decree was checked in MST 283469, effective February 19, 2026, and the relevant Annex 2 identifier is 17976571.
NHIS describes the general structure as a 20 percent inpatient share and, for ordinary outpatient care in the relevant local setting, 30 percent at a clinic, 40 percent at a hospital, and 50 percent at a general hospital. For a tertiary general hospital, its summary describes the full consultation fee plus 60 percent of the remaining benefit cost. Age, pregnancy, Medical Aid, special copay programs, fixed amounts, selective benefits, devices, prescriptions, and other exceptions can change the real bill.
For that reason, choosing an outpatient room or operating room in the detailed calculator never selects a rate automatically. If the provider gives an already calculated covered patient-payment amount, enter it without applying another percentage. If the provider instead gives the covered gross amount before patient sharing, use only the patient share percentage that the provider has confirmed for that quote.
Korean epidermoid cyst quote categories and calculator treatment| Statement category | Amount to enter | Calculator treatment |
|---|
| Covered patient payment | The patient share already calculated by the provider | No second rate |
| Covered gross amount | Gross benefit amount and confirmed patient rate | Gross × confirmed rate |
| Full patient payment | The full-patient-payment column on the statement | Add 100% |
| Non-covered charge | The provider-disclosed non-covered procedure or material price | Add 100% |
Detailed statements and non-covered disclosure matter
Article 7 of the Rule on the Standards for National Health Insurance Medical Care Benefits supports the calculation statement, receipt, and detailed breakdown of covered and non-covered items. The current rule was checked in MST 285513, effective April 15, 2026. Article 9 connects non-covered subjects to Annex 2, identifier 18095201. These rules provide a framework, but the provider and insurer must still evaluate the actual diagnosis, purpose, service, materials, and benefit criteria.
Medical Service Act Articles 45 and 45-2 govern disclosure and reporting of non-covered fees. The current act was checked in MST 285327, effective April 7, 2026. Enforcement Rule Articles 42-2 and 42-3 were checked in MST 286963, effective June 12, 2026. Disclosure lets a patient ask about an item and its price before care; it does not turn a public comparison price into a personal all-inclusive quote.
N0141 and N0142 are billing anchors, not a diagnosis-based price
A 2016 HIRA regional review considered a specific superficial abdominal epidermoid cyst. In that case, the review recognized the simple superficial skin-benign-tumor excision category rather than the submitted soft-tissue-tumor excision category. In current code labels, N0141 is an anchor for simple superficial excision of a benign skin tumor, while N0142 is an anchor for the other category reaching the muscle layer.
The review also points to the anatomic layer, lesion size, technical difficulty, and pathology result as case-specific factors. A user-entered lesion count, diameter, location, or the words epidermoid cyst cannot select N0141, N0142, or another code. Ask the provider which procedure and unit appear on the actual itemized statement.
Ask the provider
- Diagnosis, site, measured size, and depth for each lesion
- Procedure name and billing unit covering every lesion
- N0141, N0142, or the other code actually used
- Same-day additional-lesion and shared-material treatment
Do not infer
- A billing code from diameter, location, or lesion count
- A complete patient bill from one fee-schedule code
- Coverage solely from the suspected diagnosis
- A whole-quote multiplier from lesion count
HIRA published the medical and dental fee file effective January 1, 2026 after incorporating the relevant Ministry of Health and Welfare notices and conversion factors. That file is part of the billing framework, not a stand-alone retail price list. Provider type adjustments, same-day additional surgery, anesthesia, pathology, supplies, and patient-specific sharing can all affect the final statement.
Build a complete quote before calculating
- Record the scope.Note every lesion included, the largest provider-recorded diameter, the body site, the care setting, and whether the plan is still uncertain, a non-inflamed excision discussion, or a staged-care discussion after inflammation or drainage.
- Separate the statement categories.Enter covered patient payment, full patient payment, and non-covered charges in their matching fields. Switch to covered-gross mode only when the provider has supplied the pre-copay benefit amount and the applicable patient rate.
- Check every ancillary item.Add consultation and diagnostics, anesthesia and materials, pathology, medicines and dressings, and follow-up only when those amounts are outside the main operation quote.
- Add household costs.Count consultation, procedure, and follow-up visits once, then enter round-trip travel and actual uncompensated work time.
- Subtract confirmed offsets only.Use an amount that an insurer or support program has actually confirmed. Leave an unreviewed private-insurance estimate at KRW 0.
- Run the staged scenario separately.If the provider quotes inflammation-stage treatment and later removal as a separate expense, enter that full additional patient cost once instead of applying a recurrence or infection probability.
A KRW 0 field means that a quote may still be missing; it does not prove that care is free. The operation field must contain the total quote for all included lesions. If a provider starts with a per-lesion price, ask how same-day additional lesions, shared anesthesia, and shared materials are handled before converting it into one complete quote.
Detailed Korean calculator formulas
Procedure patient cost = covered patient cost + full patient payment + non-covered quote
Ancillary medical cost = consultation and diagnostics + separate anesthesia and materials + pathology + medicine and dressings + follow-up price × visits
Base gross household cost = procedure patient cost + ancillary medical cost + round-trip travel × visits + daily work loss × days
Base funding target = base gross cost − applicable confirmed offsets + contingency on the remaining net cost
Staged-care funding target = base gross cost + explicit staged-care quote − applicable confirmed offsets + contingency on that remaining net cost
Confirmed offsets are capped at each scenario’s gross cost, so the result cannot become a negative expense. The reserve is a household savings allowance, not a provider charge. The per-lesion result divides the base funding target for comparison only; it does not claim that every lesion has the same medical difficulty or price.
The English quick planner follows the same funding relationship. Put the complete itemized base gross household cost in the primary field, confirmed insurance and support in the secondary field, the desired contingency percentage in the rate field, and the preparation months in the period field. Run a second scenario after adding an explicit staged-care quote if that comparison is needed.
Worked hypothetical example
Assume two trunk lesions, the largest measuring 15 mm, with an outpatient removal discussion and a three-month funding period. Every amount below is fictional. It is not a South Korean average price, an appropriate-price opinion, a coverage decision, or an expected private-insurance payment.
Hypothetical Korean epidermoid cyst removal budget| Component | Fictional inputs | Subtotal |
|---|
| Procedure quote | KRW 180,000 covered patient + KRW 20,000 full patient + KRW 50,000 non-covered | KRW 250,000 |
| Ancillary medical | KRW 30,000 consultation + 20,000 anesthesia + 40,000 pathology + 30,000 supplies + 30,000 follow-up | KRW 150,000 |
| Household indirect cost | KRW 10,000 travel × 3 + KRW 150,000 daily work loss × 0.5 day | KRW 105,000 |
| Base gross cost | KRW 400,000 direct medical + KRW 105,000 indirect | KRW 505,000 |
| Base funding target | Subtract KRW 100,000 confirmed insurance, then add a 10% reserve | KRW 445,500 |
| Staged-care funding target | Add one explicit KRW 200,000 staged-care quote | KRW 665,500 |
The base monthly amount is KRW 148,500. The staged-care monthly amount is rounded up to KRW 221,834. Dividing the base target by two gives a comparison figure of KRW 222,750 per lesion, but it is not a lesion-specific provider price.
Clinical context without turning the budget into treatment advice
A symptom-free cyst may sometimes be observed after clinical evaluation. Incision and drainage can relieve an inflamed cyst yet may leave the cyst wall and permit recurrence. Minor complete excision aims to remove the whole cyst but can leave a scar, and significant inflammation may lead a clinician to postpone excision. These facts explain why the planner keeps a base quote and a separately confirmed staged-care quote; they do not tell any individual which treatment to choose.
Do not squeeze or cut a suspected cyst yourself. Rapid growth, fixation, repeated bleeding or ulceration, severe redness, warmth or pain, spreading swelling, fever, or chills should move attention from price comparison to prompt medical assessment. The lesion may need a different diagnosis or urgent care.
Procedure scope checklist
- Diagnosis, site, size, and depth for each lesion
- Outpatient procedure room or operating-room and admission scope
- Whole-plan quote or per-lesion starting price
- Inflammation-stage care and later removal in one or two quotes
- Wound checks and suture-removal follow-up visits
Documents and claim checklist
- Covered, full-patient-payment, and non-covered amounts
- Anesthesia, materials, pathology, medicine, and dressing scope
- Receipt and detailed calculation statement
- Insurer-required diagnosis and procedure documents
- Items that may need a HIRA medical-expense verification request
Frequently asked questions
Is every epidermoid cyst removal covered by Korean National Health Insurance?
No. The actual diagnosis, purpose, lesion status, billed service, materials, and detailed benefit criteria matter. Ask the provider and insurer to identify each covered, full-patient-payment, and non-covered item.
Should I multiply one operation quote by the number of lesions?
No, not when the quote already covers all included lesions. If a provider quotes per lesion, first ask how same-day additional lesions and shared anesthesia or materials are priced, then enter the complete plan amount.
Can N0141 determine the full procedure price?
No. A full patient bill also depends on the documented layer and difficulty, same-day additional services, provider type, anesthesia, pathology, materials, and patient-specific cost sharing.
Is pathology always a separate charge?
Pathology use and billing depend on the plan and quote. Enter KRW 0 in the separate pathology field when it is already bundled, or enter the confirmed patient amount when it is billed separately.
Should I estimate private indemnity insurance reimbursement?
Use only an amount that the insurer has confirmed after considering the actual policy and documents. Contract generation, exclusions, deductibles, outpatient or surgery limits, and claim review can change the payment, so an unreviewed estimate can understate the funding target.
Official references and next step
Legal, fee-schedule, and consumer guidance was rechecked on August 7, 2026. Recalculate from the latest itemized quote when the provider scope or Korean rules change.
Gather the provider’s written estimate and detailed statement, then enter each patient-pay component in the calculator.
The result is a household planning aid, not a diagnosis, treatment recommendation, insurer decision, or provider quotation.